http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106397159-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17fa04088f285d891117ee10818886c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-46
filingDate 2016-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9396db198628b4c20cec9bb4939183de
publicationDate 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106397159-A
titleOfInvention Synthetic method of aurone anticancer compound drug intermediate 2,4,6-trihydroxyacetophenone hydrate
abstract The invention relates to a synthetic method of aurone anticancer compound drug intermediate 2,4,6-trihydroxyacetophenone hydrate. The synthetic method comprises the following step of (i) adding 0.21 mol of phloroglucinol, 0.41 mol of 4-chlorophenethylamine, 200 ml of butyl acetate, and 0.02 to 0.025 mol of cuprous bromide in a reaction container provided with a stirrer, a thermometer and a reflux condenser, reducing the solution temperature to be 3 to 5 DEG C, controlling the stirring speed to be 100 to 120rpm, standing for 30 to 35h, filtering to obtain orange-yellow solid imine bromate, washing through butanol, placing the solid into the 3L reaction container, adding 1.5 to 1.7L of water, rising the solution temperature to be 80 to 85 DEG C, refluxing for 3 to 3.5h, decoloring through a molecular sieve, suction filtrating, washing a filter cake through a paraxylene solution, combining filter liquor and a scrubbing solution, reducing the solution temperature to be 5 to -9 DEG C, placing for 30 to 35h, filtering a precipitated colorless solid, drying at low temperature, and obtaining the 2,4,6-trihydroxyacetophenone hydrate. The mass fraction of the butyl acetate in the step (i) is 40 to 55 percent.
priorityDate 2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6443299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426109207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68073
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID101596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519592
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID101596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6537099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571617

Total number of triples: 40.